Beendigung der Haftungsfreistellung für Herstellern von COVID-19-Impfstoffen

This written question concerns the potential termination of liability exemptions granted to companies that produced COVID-19 vaccines. It seeks to clarify the legal framework regarding the responsibility of manufacturers for damages caused by these vaccines. This procedure primarily affects pharmaceutical companies and individuals who may have suffered adverse effects from vaccinations, potentially changing how legal claims for compensation are handled.